Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    MM-121-01-101
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MM-121;   Drug: Erlotinib

Study has passed its completion date and status has not been verified in more than two years.